Worried your doctor isn’t taking your back pain seriously? Here’s why scans aren’t always needed — and what actually helps ...

Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...

The FDA approved a higher dose of the GLP-1 receptor agonist semaglutide for weight loss, dubbed Wegovy HD, the agency announced on Thursday. The once-weekly injectable will come in a 7.2-mg dose -- ...

Affordable semaglutide is expected to expand globally in 2026, but experts are raising concerns about safety, side effects, ...

Recognizing the Symptoms of Stomach Cancer Many individuals often express concern about their health, leading them to seek medical advice and follow prescribed treatments. However, there are instances ...

Women tend to report more bloating, indigestion, and nausea than men,” says JoAnn Hong-Curtis, MD, a Yale Medicine gastroenterologist. “Hormonal changes across a woman’s life—and differences in ...

Trish Prosser said she was too embarrassed to tell loved ones about the type of cancer she had as she felt there was a stigma ...

With the patent for Semaglutide expiring on March 20, a number of Indian generic drug manufacturers are expected to enter the ...

PYTHON blood could hold the key to the next blockbuster weight loss treatment, scientists say. The reptiles can go months without eating after consuming a massive meal, while still remaining ...

Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo has achieved another victory as it strives to make the most out of its blockbuster GLP-1 drug in an increasingly ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an update on its ongoing regulatory interactions with the U.S. Food and Drug ...